- Core team track record advising leading global clients in approximately 100 countries.
Our Capabilities
We provide services across the program lifecycle, from designing to implementing to evaluating projects and programs. We are thoroughly versed and experienced in following strict professional standards in full compliance with F.A.R. and auditing requirements. We also work with partners to pursue funding opportunities such as federal contracts and grants, particularly those where a HUBZone partner can be a valuable addition to a team, whether by working with partners to pursue set-aside contract opportunities or by meeting HUBZone subcontracting requirements for prime contractor partners.
Program Management Services
We deliver specialized services by working with partners to engage in and support implementation and research efforts including:
Program planning, management and evaluation
Strategic and operational analysis
Capacity building
Program performance measurement and improvement
R&D in life sciences
Compliance and reporting
We work through our extensive network of partners and collaborators to implement technical assistance and research programs.
Our professionals have a long history of work with U.S. Government agencies (USAID, NIH, Navy, Army, Air Force, USDA and other agencies), international organizations such as World Bank and United Nations, and leading companies and foundations such as the Bill and Melinda Gates Foundation, and universities.
We have the ability to provide expertise and personnel and other resources for a range of R&D activities, from basic research to product development and commercialization.
Proprietary Technologies
We also own proprietary technologies that may be shared under limited license arrangements to further R&D in those areas. Examples of these are our patented technologies for use in development of a new generation of malaria vaccines, development of a universal antivenom, and other areas.
- Novel Antigen For Use In Malaria Vaccine (Active Patents in USA and other countries)
- MRNA Malaria Vaccine (Patent Pending)
- Universal Antivenom (Active Patents in USA and other countries)
